Status:
COMPLETED
Effect of Heart Valve Replacement on Cheyne-Stokes Respiration
Lead Sponsor:
Nanjing Medical University
Conditions:
Cheyne-Stokes Respiration
Heart Valve Disease
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
Sleep disordered breathing, especially central sleep apnea, is common in patients with chronic heart failure. Heart valve replacement could have some effect on central sleep apnea. The aim of the stud...
Detailed Description
Sleep apnea, especially central sleep apnea, has a high prevalence in patients with chronic heart failure. Although sleep disordered breathing (SDB) have been described in patients with heart disease,...
Eligibility Criteria
Inclusion
- heart valve disease with any ejection fraction
- clinical diagnosis of Cheyne-Stokes respiration
Exclusion
- unstable heart failure
- stroke
- transient ischemic attack in last 6 months
- pacemaker, cardioverter-defibrillator or resynchronization device implanted less than 6 months before study entrance
- severe chronic obstructive pulmonary disease
Key Trial Info
Start Date :
September 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2012
Estimated Enrollment :
26 Patients enrolled
Trial Details
Trial ID
NCT01426776
Start Date
September 1 2010
End Date
July 1 2012
Last Update
February 26 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The First Affiliated Hospital of Nanjing Medical University
Nanjing, Jiangsu, China, 210029